Prion protein gene polymorphism and Alzheimer's disease: one modulatory trait of cognitive decline?

Open Access
Publisher Website
Google Scholar
Abstract
Although its main biological function is still unknown, the prion protein is involved in normal synaptic function.1Interestingly, the presence of a valine (V), replacing a methionine (M) at codon 129 of the prion protein gene (PRNP), has been associated with poor performance in cognitive tests in a large cohort of aged, non-demented, French people.2 Accordingly, this polymorphic gene represents a suitable candidate for an association with Alzheimer's disease, a dementing disorder characterised by neuronal degeneration and synaptic loss. To assess whether the PRNP V/M codon129 polymorphism—alone or in combination with polymorphisms in the apolipoprotein (APO)E3 and interleukin (IL)-1α4 genes, already shown to be associated with Alzheimer's disease—affects the occurrence or clinical features of the disease, we performed a case-control study in a cohort of Italian patients with sporadic Alzheimer's disease and age matched healthy controls. Venous blood was collected from 212 Italian patients (130 women, 82 men; mean (SD) age at disease onset 68.3 (8.0) years) affected by clinically probable Alzheimer's disease, according to McKhann's criteria. Patients were also divided into those with early disease onset (⩽65 years; 72 patients; mean (SD) age at disease onset 57.0 (7.5) years), and those with a late onset (>65 years; 140 patients; mean (SD) age …

This publication has 0 references indexed in Scilit: